The PHIP mutation was associated with core neuropsychiatric symptoms, including anxiety and depression, whereas the CLCN4 mutation contributed to severe brain atrophy observed in neuroimaging, further exacerbating cognitive and behavioral deficits. The gene discussed is PHIP; the disease is depressive symptom measurement.